OROFLOW

Serial Number 99171033
686

Registration Progress

Application Filed
May 6, 2025
Under Examination
Approved for Publication
Dec 2, 2025
Published for Opposition
Dec 2, 2025
Registered

Attorney Assistance

Published for Opposition
Due: Jan 01, 2026 1 days

Trademark Image

OROFLOW

Basic Information

Serial Number
99171033
Filing Date
May 6, 2025
Published for Opposition
December 2, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Dec 2, 2025
Application
Pending
Classes
005

Rights Holder

LTR Pharma Limited

99
Address
9/204 Alice Street
Brisbane City, QLD 4000
AU

Ownership History

LTR Pharma Limited

Original Applicant
99
Brisbane City, QLD AU

LTR Pharma Limited

Owner at Publication
99
Brisbane City, QLD AU

Legal Representation

Attorney
Douglas N. Masters

USPTO Deadlines

Next Deadline
1 days remaining
Published for Opposition
Due Date
January 01, 2026
Extension Available
Until February 01, 2026

Application History

14 events
Date Code Type Description Documents
Dec 2, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 2, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 4, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 15, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 15, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 15, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 24, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 24, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 23, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 6, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 6, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 6, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for treatment of oesophageal motility disorders; nasal sprays for treatment of oesophageal motility disorders

Classification

International Classes
005